<DOC>
	<DOCNO>NCT01421121</DOCNO>
	<brief_summary>A randomized , placebo-controlled , double-blind clinical trial evaluate safety immunogenicity new inactivated EV71 vaccine develop Sinovac Biotech CO. , LTD .</brief_summary>
	<brief_title>Safety Immunogenicity Inactivated EV71 Vaccine Infants</brief_title>
	<detailed_description />
	<mesh_term>Enterovirus Infections</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Aluminum Hydroxide</mesh_term>
	<criteria>1 . Healthy male female , age 6 month 11 year old Health determine medical history , physical examination , laboratory examination clinical judgment investigator 2 . Provided legal identification sake recruitment . 3 . Subjects and/or parent ( ) /legal guardian ( ) able understand sign inform consent . 4 . Birth weight 2500 gram 1 . History Handfootmouth Disease 2 . Subject allergic history vaccine , allergic ingredient vaccine 3 . Serious adverse reaction vaccine anaphylaxis , hive , respiratory difficulty , angioedema , abdominal pain 4 . Congenital malformation developmental disorder , genetic defect , severe malnutrition 5 . Epilepsy , seizures convulsion history , family history mental illness 6 . Autoimmune disease immunodeficiency , parent , brother sister autoimmune disease immunodeficiency 7 . History asthma , angioedema , diabetes malignancy 8 . History thyroidectomy thyroid disease require medication within past 12 month 9 . Bleeding disorder diagnose doctor ( e.g . factor deficiency , coagulopathy , platelet disorder require special precaution ) significant bruise bleed difficulty IM injection blood draws 10 . Asplenia , functional asplenia condition result absence removal spleen 11 . Acute illness acute exacerbation chronic disease within past 7 day 12 . Any history immunosuppressive medication cytotoxic medication inhale corticosteroid within past six month ( exception corticosteroid nasal spray allergic rhinitis topical corticosteroid acute uncomplicated dermatitis ) 13 . History blood product within 3 month 14 . Administration live attenuate vaccine within 28 day 15 . Administration subunit inactivate vaccine , e.g. , pneumococcal vaccine , allergy treatment within 14 day 16 . Axillary temperature &gt; 37.0 centigrade vaccination 17 . Abnormal laboratory parameter vaccination 18 . Any medical , psychiatric , social condition , occupational reason responsibility , judgment investigator , contraindication protocol participation impair volunteer 's ability give inform consent</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>November 2012</verification_date>
</DOC>